Clinical Trial Update: Actuate 1901: 9-ING-41 in Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for 9-ING-41 in myelofibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• 9-ING-41

Snippet

Sponsor: Actuate Therapeutics Inc. | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED